EUVIMEDDécouvrir EUVIMED
Open access · CC BY-NC 4.0

Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis

Cailin He, Ziqin Liu, Yanchun Yuan, Linxin Tang iD, Meirong Wang, Yongchao Li, Qianqian Zhao, Ling Weng, Juan Du, Hanjun Wu, Fan Hu, Renshi Xu iD and 4 more

European Journal of Neurology · 2026-06 · 33 (6)

DOI: 10.1111/ene.70653 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2026-06-01. Written by Cailin He and 15 co-authors. Institution: Department of Neurology, Xiangya Hospital, Central South University, Jiangxi (National Regional Center for Neurological Diseases), Nanchang, Jiangxi,…. Major MEDLINE topics: Amyotrophic Lateral Sclerosis, Nerve Tissue Proteins. 28 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: the National Key R&D Program of China, National Science and Technology Innovation 2030 Major Program, the National Natural Science Foundation of China.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Background

UNC13A is a genetic modifier of amyotrophic lateral sclerosis (ALS) in European populations, but its role in Chinese patients remains incompletely characterized. We investigated the spectrum of UNC13A variation and its impact on disease risk and progression in a Chinese ALS cohort.

Methods

We performed an integrated genetic analysis of 1,533 Chinese ALS patients and 1,405 controls, including rare variant burden testing, genome‐wide survival analysis, haplotype mapping, and conditional analyses. An integrated clinical‐genetic prognostic score was developed and validated.

Results

Rare deleterious UNC13A variants were not associated with ALS risk. We identified two independent haplotype blocks with distinct clinical impacts. Block 1 (tagged by rs75421007) was associated with reduced baseline muscle strength ( p = 0.030), while Block 2 (tagged by rs78549703), a brain‐specific splicing QTL, was the primary driver of survival heterogeneity. The European variant rs12608932 showed a survival association in single‐marker analysis ( p = 0.024), but conditional analyses revealed its effect was not independent of Block 2. An integrated prognostic score combining clinical factors and Block 2 haplotype stratified patients into low‐, intermediate‐, and high‐risk groups (median survival: 52.6, 37.1, and 32.0 months; p < 0.001), with decision curve analysis confirming clinical utility.

Conclusions

This study delineates UNC13A genetic architecture in Chinese ALS, identifying two independent haplotype blocks that differentially influence disease severity and survival. The Block 2 haplotype, which includes a brain sQTL, is a major determinant of survival heterogeneity and may inform patient stratification in future studies.

Subjects

MeSH terms (MEDLINE)

Amyotrophic Lateral SclerosisNerve Tissue ProteinsAdultAgedFemaleHumansMaleMiddle AgedGenetic Predisposition to DiseaseGenome-Wide Association StudyHaplotypesPolymorphism, Single NucleotideSeverity of Illness IndexEast Asian People

Author keywords

Chinese populationUNC13Aamyotrophic lateral sclerosisgenetic modifierhaplotypeprognostic model

Substances

Nerve Tissue ProteinsUNC13B protein, human

Authors and institutions

  • Department of Neurology, Xiangya Hospital, Central South University, Jiangxi (National Regional Center for Neurological Diseases), Nanchang, Jiangxi, P. R. China.
  • National Clinical Research Center for Geriatric Diseases (Xiangya Hospital of Central South University), Changsha, Hunan, P. R. China.
  • Key Laboratory of Hunan Province for Neurodegenerative Disorders, Central South University, Changsha, Hunan, P. R. China.
  • Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, P. R. China.
  • Engineering Research Center of Hunan Province for Cognitive Impairment Disorders, Central South University, Changsha, Hunan, P. R. China.
  • Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, Hunan, P. R. China.

ORCID profiles: Linxin Tang, Renshi Xu, Jifeng Guo, Lu Shen, Beisha Tang, Junling Wang

Funding

  • the National Key R&D Program of China
  • National Science and Technology Innovation 2030 Major Program
  • the National Natural Science Foundation of China
  • the Jiangxi Provincial Natural Science Foundation
  • the Ganpo Outstanding Talents Support Program-Cultivation Project for Academic and Technical Leaders in Key Disciplines
  • the Ganpo Talents Program-Innovation Leading Talent Project (Medical and Health Care Category)
  • the Jiangxi Provincial Health Technology Project

Cite

APA

He, C., Liu, Z., Yuan, Y., Tang, L., Wang, M., Li, Y., Zhao, Q., Weng, L., Du, J., Wu, H., Hu, F., Xu, R., Guo, J., Shen, L., Tang, B., & Wang, J. (2026). Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis. European Journal of Neurology, 33(6). https://doi.org/10.1111/ene.70653

Vancouver

He C, Liu Z, Yuan Y, Tang L, Wang M, Li Y, et al. Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis. European Journal of Neurology. 2026;33(6). doi:10.1111/ene.70653

BibTeX
@article{He2026,
  author = {He, Cailin and Liu, Ziqin and Yuan, Yanchun and Tang, Linxin and Wang, Meirong and Li, Yongchao and Zhao, Qianqian and Weng, Ling and Du, Juan and Wu, Hanjun and Hu, Fan and Xu, Renshi and Guo, Jifeng and Shen, Lu and Tang, Beisha and Wang, Junling},
  title = {Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {6},
  doi = {10.1111/ene.70653}
}
Start for free →